Latin America Gastrointestinal Therapeutics Market
The gastrointestinal therapeutics market in Latin America is expected to reach a projected revenue of US$ 2,264.6 million by 2033. A compound annual growth rate of 2.2% is expected of Latin America gastrointestinal therapeutics market from 2026 to 2033.
Latin America gastrointestinal therapeutics market highlights
The Latin America gastrointestinal therapeutics market generated a revenue of USD 1,907.5 million in 2025.
The market is expected to grow at a CAGR of 2.2% from 2026 to 2033.
In terms of segment, branded was the largest revenue generating drug type in 2025.
Generics is the most lucrative drug type segment registering the fastest growth during the forecast period.
Country-wise, Argentina is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 1,907.5 million
Market revenue in 2033
USD 2,264.6 million
Growth rate
2.2% (CAGR from 2026 to 2033)
Largest segment
Branded
Fastest growing segment
Generics
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Branded, Generics
Key market players worldwide
AbbVie Inc, AstraZeneca PLC, Bausch Health Companies Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Abbott Laboratories, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Cipla Ltd DR, Gilead Sciences Inc, Biogen Inc, Organon & Co Ordinary Shares
Other key industry trends
In terms of revenue, Latin America region accounted for 4.5% of the global gastrointestinal therapeutics market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 14,565.1 million by 2033.
Latin American gastrointestinal therapeutics market consists of Brazil, Mexico, and other Latin American countries. Rapidly developing economies, presence of leading pharmaceutical companies, evolving healthcare infrastructure, and increasing prevalence of gastroenterological diseases in these regions are major factors expected to drive the Latin America market during the forecast period.
In addition, presence of untapped opportunities, economic development, and rising patient awareness are some other factors anticipated to drive rapid growth of this region.
Latin America gastrointestinal therapeutics market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gastrointestinal Therapeutics Market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 61.43% in 2025.
Horizon Databook has segmented the Latin America gastrointestinal therapeutics market based on branded, generics covering the revenue growth of each sub-segment from 2021 to 2033.
Latin American gastrointestinal therapeutics market consists of Brazil, Mexico, and other Latin American countries. Rapidly developing economies, presence of leading pharmaceutical companies, evolving healthcare infrastructure, and increasing prevalence of gastroenterological diseases in these regions are major factors expected to drive the Latin America market during the forecast period.
In addition, presence of untapped opportunities, economic development, and rising patient awareness are some other factors anticipated to drive rapid growth of this region.
Latin America Gastrointestinal Therapeutics Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
Branded
Generics
Latin America Gastrointestinal Therapeutics Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
Aminosalicylates
Digestive Enzymes
Proton Pump Inhibitors
Laxatives
Anti-emetics
H2 Antagonists
Anti-diarrheals
Biologics/Biosimilar
Other Drug Classes
Latin America Gastrointestinal Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Injectables
Others Route of Administrations
Latin America Gastrointestinal Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
Crohn's disease
Ulcerative colitis
GERD
IBS
Others Applications
Latin America Gastrointestinal Therapeutics Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Reasons to subscribe to gastrointestinal therapeutics market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gastrointestinal therapeutics market databook
Our clientele includes a mix of gastrointestinal therapeutics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America gastrointestinal therapeutics market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America gastrointestinal therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Gastrointestinal Therapeutics Market, 2021-2033 (US$M)